TNF and mucopolysaccharidosis: Moreover, animal models and case reports of MPS have revealed joint abnormalities similar to those seen in inflammatory joint disease and improvements in inflammation, joint pathology, and physical function when treated with TNF-α inhibition [60,61,62].